TrialJournal of cancer research and clinical oncology2007

Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium.

Kim Margolin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.